Clean Science and Technology Ltd (CLEAN) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Clean Science demonstrated robust cross-cycle EBITDA margins and firm growth plans despite challenging times for the chemical industry.
- The company's agility and strong fundamentals contributed to its continued positive performance.
- Standalone Q3 FY25 results show steady revenues with a 40%/60% domestic/international sales mix. EBITDA increased by 8% Q-o-Q to Rs. 102 crores (45% margin) due to favorable product mix and utility costs. Profitability increased by 10% to Rs. 74 crores (32.5% margin).
- Year-on-year, standalone sales increased by 20% (primarily volume-driven), leading to 18% EBITDA growth and 19% profitability growth.
- Consolidated Q3 FY25 results show Rs. 240 crores in sales (up 23% Y-o-Y), Rs. 98 crores EBITDA (up 14% Y-o-Y, 10% Q-o-Q, 41.5% margin), and Rs. 66 crores profit (up 5% Y-o-Y, 11% Q-o-Q).
- HALS sales volume reached approximately 190 tons per month, with a December exit rate of 200 tons per month.
- Two new products were commercialized: DHDT (a pharma intermediate) and BHT (for the Performance segment).
- Sales contribution remained consistent: Performance (69%), Pharma (18%), and Agro (13%).
- Rs. 160 crores CAPEX incurred in 9M FY25, primarily for the Clean Fino-Chem subsidiary.
- Solar capacity expanded by 400 kilowatts at the subsidiary.
- Interim dividend of Rs. 2 per share approved.
- Future growth expected from scaled-up HALS production and the new pharma intermediate.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.